A Phase Ib Study With Pegylated Recombinant Human Endostatin in Advanced / Metastatic NSCLC or Other Solid Tumors
Condition(s):NSCLC; Solid TumorLast Updated:June 2, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):NSCLC; Solid TumorLast Updated:June 2, 2020Unknown status
Condition(s):CancerLast Updated:November 29, 2023Recruiting
Condition(s):Non-small Cell Lung CancerLast Updated:April 15, 2022Unknown status
Condition(s):Lung Neoplasm Malignant; Resectable Lung Non-Small Cell CarcinomaLast Updated:March 7, 2022Completed
Condition(s):Non Small Cell Lung Cancer; HealthyLast Updated:February 21, 2023Recruiting
Condition(s):Non-Small Cell Lung CancerLast Updated:March 28, 2022Recruiting
Condition(s):Melanoma; Non Small Cell Lung CancerLast Updated:August 2, 2023Active, not recruiting
Condition(s):Decision Making, Shared; Stereotactic Body Radiation Therapy; Lung Cancer, Non-small Cell; Radiation Toxicity; Lung MetastasesLast Updated:October 31, 2023Recruiting
Condition(s):Lung Cancer, Non-Small Cell; NeoplasmsLast Updated:December 16, 2022Terminated
Condition(s):Non-small Cell Lung Cancer Metastatic; Breast Cancer Female; Colon CancerLast Updated:February 11, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.